第一单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
作者：
Katsuhiro,Togami [1]
;
Sun Sook,Chung [1]
;
Vikas,Madan [2]
;
Christopher A G,Booth [1]
;
Christopher M,Kenyon [1]
;
Lucia,Cabal-Hierro [1]
;
Justin,Taylor [3]
;
Sunhee S,Kim [1]
;
Gabriel K,Griffin [4]
;
Mahmoud,Ghandi [5]
;
Jia,Li [2]
;
Yvonne Y,Li [1]
;
Fanny,Angelot-Delettre [6]
;
Sabeha,Biichle [6]
;
Michael,Seiler [7]
;
Silvia,Buonamici [7]
;
Scott B,Lovitch [8]
;
Abner,Louissaint [9]
;
Elizabeth A,Morgan [8]
;
Fabrice,Jardin [10]
;
Pier Paolo,Piccaluga [11]
;
David M,Weinstock [12]
;
Peter S,Hammerman [1]
;
Henry,Yang [2]
;
Marina,Konopleva [13]
;
Naveen,Pemmaraju [13]
;
Francine,Garnache-Ottou [6]
;
Omar,Abdel-Wahab [14]
;
H Phillip,Koeffler [15]
;
Andrew A,Lane [16]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
[1]
Cancer Science Institute of Singapore, National University of Singapore, Singapore.
[2]
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.;Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, Florida.
[3]
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.;Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
[4]
Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
[5]
Université Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
[6]
H3 Biomedicine, Cambridge, Massachusetts.
[7]
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
[8]
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
[9]
Inserm U1245, Centre Henri Becquerel, Université de Rouen, IRIB, Rouen, France.
[10]
Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School, Bologna, Italy.;Department of Biomolecular Strategies, Genetics, Avant-Garde Therapies and Neurosciences (SBGN), Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy.;School of Health, Department of Pathology, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
[11]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
[12]
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[13]
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
[14]
Cancer Science Institute of Singapore, National University of Singapore, Singapore.;Cedars-Sinai Medical Center, Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, California.;Department of Hematology-Oncology, National University Cancer Institute of Singapore (NCIS), National University Hospital, Singapore.
[15]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. andrew_lane@dfci.harvard.edu.;Broad Institute of Harvard and MIT, Cambridge, Massachusetts.;Ludwig Center at Harvard, Boston, Massachusetts.
[16]
DOI
10.1158/2159-8290.CD-20-1513
PMID
34615655
发布时间
2023-04-18
换一批
